Chemical Kinetics
Presentation 2 TRAILBLAZERALZ 2 A Phase 3 Study to Assess Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's Disease, Paul Solomon 1, Jennifer Zimmer 2, Cynthia D Evans 2, Ming Lu 2, John R Sims 2, Dawn A Brooks 2, Mark A Mintun 2,3 (1 Boston Center for Memory, Boston, MA, (United States), 2My Engineering Math An unknown radioactive element decays into nonradioactive substances
